INTERNATIONAL BIOPHARMACEUTICAL ASSOCIATION

SUBMIT YOUR ARTICLE TO IBPA ASSOCIATION

For the year 2008

The Publishing Committee of IBPA has developed and approved a list of articles to be published in IBPA publications in 2008.

Authors (Volunteers) are invited to submit a request to write the following articles to

info@ibpassociation.org .

You can also propose your own title not included in this list. When submitting, please attach your resume or mention your affiliation with the industry.

Paper Submission Guidelines

As a general guideline, the papers should be 4,000-to-5,000 words in length.

Submit your Full Paper in the following format:

Margins: One inch/2.5cm all around.
Font: Times New Roman 12-point, single-spaced.
Submitted in MS Word format.
File size limit - 1MB - please use low-resolution graphics.
Title Page: include the following (see example):
Copy & paste this header (Verdana 8pt) and insert at top of title page:

International Biopharmaceutical Association Publication

Paper title (bold and centered)
Full contact information of all authors (left-justified), on title page.
Summary/abstract of 100-to-300 words.
Full paper with references and notes.

Please submit your paper to

info@ibpassociation.org

Published Articles

Under Review

Work In Progress

Unpublished Topics

ARTICLES PUBLISHED IN IBPA NEWSLETTERS

Title	Author's Name	Author's e-mail
January 2005 Issue
The Role of ICH GCP, Recruitment Strategies, and Training of Clinical Sites Staff in Successful Patient Recruitment Rates	Dr. Marithea Goberville	msg@scienceauthor.com
Safety in Clinical Trials: Who is Responsible?	Ariel E. Quinio, Ph.D. candidate	arielq21@yahoo.ca
SOP Writing for Clinical Trials: Staff Training Aspects	Akanksha Saxena	akanksha76@yahoo.com
February 2005 Issue
Careers for Nurses in the Biopharmaceutical Industry	Kristin Hudasek, B.Sc., M.Sc.	info@ibpassociation.org
Practices in Pharmaceutical Marketing	Editorial Publication	info@ibpassociation.org
Introducing Change into Research and Development Organization	Hugh G. Davis, Senior Instructor , Kriger Biopharmaceutical Career Training Program	info@kriger.com
March 2005 Issue
Things Can Go Awry During the Drug Approval Process.	Editorial Publication	info@ibpassociation.org
Internet Technologies for the Biopharmaceutical Industry	Editorial Publication	info@ibpassociation.org
Six Sigma history, current status and future horizons	Editorial Publication	info@ibpassociation.org
April 2005 Issue
The Effects of Haloperidol on Locomotor Activity and Dopamine Levels in the Brain	Ashlee McElwain	ashleemcelwain@yahoo.com
Clinical Research Outsourcing Overview: Current Scenario & Future Outlook	Dr. Jayashree	maheshjayashree@yahoo.com
May 2005 Issue
Successful Biopharmaceutical Project Planning: How to Get it Right from the Beginning,	Subhadra Modukuri	subhadrakumar@yahoo.com
The Development of Drugs Used in Treatment of Asthma: Overview of Past Achievements.	Brigette Hales, MSc.	bhales@hotmail.com
The effectiveness of technology transfer is one of the key determinants in the success of a contract-manufacturing project.	Editorial Publication	info@ibpassociation.org
June 2005 Issue
Pharmacogenetic Discrimination: Ethical Lessons for the Biopharmaceutical Industry	Michael S. Jackson	pokey127@cogeco.ca
Financial Disclosure by Clinical Investigators	Shilpa Bengeri	sshilpa12@yahoo.com
Drug Recall: Effects on Consumer Confidence.	Eddy Mutumba MLT	eddymutumba@yahoo.com
New Ways to Fight Flu. What Can We Offer?	Akila	akilajude@rogers.com
Pre-clinical Research: How it Could Be Done Faster and More Efficient?	Lijy Sunil	lijysunil@yahoo.com
Fraud in Clinical Trials: Is it Really an Issue?	Patrick Busby	ptbusby@hotmail.com
July 2005 Issue
Novel histamine therapy undergoing clinical trials in patients with Alzheimer's Disease.	O'Rita M. Siddall	o_siddall@yahoo.com
Development of New Antibiotics: Does it Really Pay off?	Nasima Khan	nasimak@sympatico.ca
Drug Approval Process in the USA and Canada: Does it guarantee the patient's safety?	Samna Ghani	samna_ghani@yahoo.com
Regulatory Agencies Do Not Require Clinical Trials To Be Expensive!	David Mills	hyperionmaximus@hotmail.com
August 2005 Issue
Bioinformatics: The Effects on the Cost of Drug Discovery and Development	F. Nyachoto	FranciscaN@hcrnam.com
Importance of Informed Consent in Clinical trials: How to check the patient’s Understanding”	Dr. Sonal Patel	drsp77@yahoo.com
Biopharmaceutical aspects of New Hormone Treatments	Ananda M. Mooliya. MSc. Organic Chemistry.	anandrajni113682002@yahoo.com
September 2005 Issue
Clinical Trials in Greece Not Any More "Terra Incognita" for the Rest of the World	K. Papataxiarchou & J. Darsinou	CORONIS Research SA http://www.coronis.gr
Does the Biopharmaceutical Industry Really Want to Cure Hypertension	O. Ogunmefun	tunog3@yahoo.ca
New Chemotherapy Delivery Methods	L. Danridge
October 2005 Issue
Quality Assurance In New Drug Development & Research	Darshit S Patel	darshit1979@rediffmail.com
Role of Biopharmaceuticals and Biotechnology in Dentistry	Dr.Jyothi Kudasomannavar. (B.D.S)	dentist_jyothi@yahoo.com
Six Sigma and the Pharmaceutical Industry	Victoria Matalog Almario	vickie@rogers.com
Lipid-Lowering Drugs: What is Good for Industry	Florencita Cabrera	Reynaldorcb@aol.com
Oncological Clinical Trials	Sruman Bandaru	sruman_bandaru@yahoo.com
November 2005 Issue
Drug Delivery Devices: Nanotechnology - Where Are You?	Isabella.R. Vincent	isavinr@gmail.com
Clinical Trials in Bulgaria	Stefan Milenkov	milenkov@web.de
How Biotechnology can Fight a Heart Attack?	Asif I Qureshi	aiq@gadball.com
December 2005 Issue
Biotechnological Revolution: Who will regulate Biotechnological Innovations on a Global Scale?	Josefa L. Binker, MD	binker@bellsouth.net
Benchmarking and Metrics in Quality Management of Clinical Trials-A Myth, Magic or Reality	Dr. Balvinder Arora	dr_arorabalvinder007@yahoo.com
The Future of Drug Discovery and Drug Development.	Adrian Dobrowsky	acdsky77@gmail.com
"Effects of Sarbanes-Oxley on the Pharmaceutical Industry"?	Jayanthi Ramakrishnan	sjayanthir@yahoo.com